Catto - Figure 3
Bladder Cancer Costs
FIG. 3: Bladder cancer is an important healthcare problem. It is an extremely common cancer, ranked as fifth, sixth, or seventh most common, depending on how you define it, and it is one of the most expensive human malignancies to manage. Figure 3 shows the annual costs of bladder cancer across the European Union, up to €13,000 per patient per year,[2] which combined with the incidence and the long natural history of bladder cancer adds up to a huge financial burden for healthcare sectors. Bladder cancer is probably the third or fourth most prevalent cancer because of its long natural history,[1] and as a consequence, we need to focus on follow-up.
References
World Health Organization (WHO), International Agency for Research on Cancer (IARC). GLOBOCAN 2012 v1.0: Estimated cancer mortality, incidence and prevalence worldwide in 2012 http://globocan.iarc.fr Accessed July 21, 2017
Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic burden of bladder cancer across the European Union. Eur Urol. 2016;69:438–47 https://doi.org/10.1016/j.eururo.2015.10.024
